Nuclear Cardiology and Myocardial Perfusion Imaging

Nuclear cardiology uses radioactive tracers and gamma-ray imaging to assess heart muscle function, blood flow, and viability — information that anatomic tests alone cannot reliably provide. Myocardial perfusion imaging (MPI) is the most widely performed nuclear cardiology procedure and plays a central role in diagnosing coronary artery disease, guiding revascularization decisions, and stratifying cardiac risk. This page covers the definition and scope of nuclear cardiology, how MPI protocols work mechanistically, the clinical scenarios in which these tests are ordered, and the decision boundaries that distinguish appropriate from inappropriate use. The broader regulatory and oversight framework for cardiac imaging is addressed at Regulatory Context for Cardiology.

Definition and scope

Nuclear cardiology is the subspecialty of cardiology that applies radionuclide techniques to evaluate myocardial perfusion, ventricular function, and cardiac innervation. The American Society of Nuclear Cardiology (ASNC) defines the field's scope through its imaging guidelines, which cover tracer selection, acquisition protocols, radiation dosimetry, and reporting standards.

The two principal radiotracers used in MPI are:

• Technetium-99m (Tc-99m) agents — including sestamibi (Cardiolite) and tetrofosmin (Myoview), both of which emit 140 keV gamma photons and carry effective radiation doses typically in the range of 9–12 millisieverts (mSv) for a standard rest/stress study (ASNC, Imaging Guidelines for Nuclear Cardiology Procedures)
• Thallium-201 (Tl-201) — an older tracer with higher radiation burden, now used less frequently as primary imaging agent given the dosimetric advantages of Tc-99m compounds

A third modality, rubidium-82 (Rb-82) PET perfusion, uses positron emission tomography rather than single-photon emission computed tomography (SPECT). Rb-82 PET carries an effective dose of approximately 3–5 mSv and provides superior spatial resolution and absolute flow quantification compared to SPECT, according to ASNC technical standards.

The Nuclear Regulatory Commission (NRC) governs the medical use of radioactive materials under 10 CFR Part 35, which establishes authorized user requirements, written directive obligations for therapeutic uses, and records requirements for diagnostic administrations.

How it works

MPI protocols involve two imaging phases — stress and rest — that together allow differentiation between ischemia (reversible perfusion deficit) and infarction (fixed perfusion deficit).

Acquisition sequence (standard SPECT protocol):

1. Stress induction — exercise treadmill (Bruce or modified Bruce protocol) or pharmacologic vasodilation with adenosine, regadenoson (Lexiscan), or dipyridamole. Dobutamine is reserved for patients with contraindications to vasodilators.
2. Tracer injection — Tc-99m sestamibi or tetrofosmin is injected at peak stress; the tracer distributes proportional to myocardial blood flow at the moment of injection.
3. Stress image acquisition — begins 15–45 minutes post-injection, allowing hepatic clearance.
4. Rest injection and imaging — a second tracer dose is given at rest; images are typically acquired 30–60 minutes later.
5. Reconstruction and gating — ECG-gated SPECT allows simultaneous assessment of wall motion and ejection fraction alongside perfusion.

The gamma camera detects photons emitted from the tracer retained in myocardial cells and reconstructs tomographic slices in three standard orientations: short axis, vertical long axis, and horizontal long axis. Summed stress scores (SSS), summed rest scores (SRS), and summed difference scores (SDS) are derived from 17-segment polar maps using a standardized scoring system endorsed by ASNC and the American College of Cardiology (ACC).

PET MPI differs in that it uses coincidence detection of 511 keV annihilation photons, enabling attenuation correction and absolute myocardial blood flow quantification in mL/min/g — a capability that SPECT cannot routinely provide.

Common scenarios

Nuclear cardiology testing is applied across a well-defined set of clinical presentations:

• Stable chest pain evaluation — when coronary artery disease is suspected but pre-test probability is intermediate, MPI provides functional evidence of ischemia that anatomic CT angiography may not
• Known CAD with symptom change — to identify new or worsening ischemia without repeat catheterization
• Pre-operative risk stratification — for patients undergoing major non-cardiac surgery who have elevated cardiac risk indices, per ACC/AHA perioperative guidelines
• Post-revascularization assessment — confirming adequate perfusion after angioplasty and stenting or bypass surgery
• Viability assessment — in patients with left ventricular dysfunction, Tl-201 redistribution imaging or FDG-PET (fluorodeoxyglucose positron emission tomography) distinguishes hibernating viable myocardium from scar tissue, informing decisions about coronary artery bypass surgery
• Heart failure workup — to determine whether ischemic etiology is driving ventricular dysfunction

The ACC Appropriate Use Criteria for Radionuclide Imaging, published jointly with ASNC, categorize clinical indications as Appropriate, May Be Appropriate, or Rarely Appropriate. The 2023 AUC update maintained nuclear MPI as appropriate for intermediate-risk symptomatic patients and as appropriate following an inconclusive prior stress test.

Decision boundaries

Selecting nuclear MPI over alternative stress imaging modalities requires weighing diagnostic yield, radiation exposure, availability, and patient-specific factors.

SPECT vs. PET:

Nuclear MPI vs. stress echocardiography — stress echo carries zero ionizing radiation and provides real-time valve and pericardial assessment, making it preferable in younger patients and those with known cardiomyopathy where wall motion data is the primary question. Nuclear MPI has superior sensitivity for detecting mild ischemia and performs better in obese patients when attenuation-corrected SPECT or PET is used.

Nuclear MPI vs. CT coronary angiography — CT coronary angiography provides anatomic stenosis severity but not hemodynamic significance; MPI directly measures flow-limiting ischemia. Guidelines support MPI when functional assessment is the primary goal or when CT findings are ambiguous.

Absolute contraindications and safety limits — pharmacologic stress with adenosine or regadenoson is contraindicated in second- or third-degree AV block (without pacemaker) and in active bronchospasm. Pregnancy is a relative contraindication given fetal radiation exposure; the Nuclear Regulatory Commission sets occupational exposure limits at 50 mSv/year for radiation workers, with a fetal dose limit of 5 mSv over the gestation period under 10 CFR 20.1208.

Interpreting cardiologists in nuclear cardiology are expected to meet training requirements defined in ASNC's Certification in Nuclear Cardiology (CNuC) framework, and laboratories seeking accreditation are assessed through the Intersocietal Accreditation Commission (IAC) Nuclear/PET program, which evaluates equipment quality control, protocol adherence, and reporting consistency.

References

• American Society of Nuclear Cardiology (ASNC) — Imaging Guidelines for SPECT Nuclear Cardiology Procedures
• American College of Cardiology — Appropriate Use Criteria for Radionuclide Imaging
• U.S. Nuclear Regulatory Commission — 10 CFR Part 35: Medical Use of Byproduct Material
• U.S. Nuclear Regulatory Commission — 10 CFR 20.1208: Dose to Embryo/Fetus
• Intersocietal Accreditation Commission (IAC) — Nuclear/PET Accreditation Standards
• ACC/AHA 2014 Guidelines on Perioperative Cardiovascular Evaluation — American College of Cardiology

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)